🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the best dose and side effects of mogamulizum...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-10-24
Trial ID
NCT03309878
Treatments Being Tested
This phase II trial tests how well nemtabrutinib in combination with pembro...
Status
Recruiting
Location
Roswell Park Cancer Institute
Start Date
2026-08-15
Trial ID
NCT06863402
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This phase I trial studies the side effects and best dose of ziv-aflibercep...
Status
Active Not Recruiting
Location
Moffitt Cancer Center-International Plaza
Start Date
2015-04-08
Trial ID
NCT02298959
This phase II trial compares the impact of brentuximab vedotin and nivoluma...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07572123
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
This phase II trial studies how well pembrolizumab and epacadostat work in ...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2018-12-21
Trial ID
NCT03602586
Treatments Being Tested
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067
This phase II trial tests how well pembrolizumab and tazemetostat work to t...
Status
Active Not Recruiting
Location
Northwestern University
Start Date
2024-09-30
Trial ID
NCT06242834